Martin Price

Views & Analysis

The world of life sciences is changing rapidly, and the traditional ways of assessing drugs may no longer be fit for purpose.

News

Agios is planning to file its sickle cell disease candidate mitapivat with the FDA under the accelerated pathway within the next few months.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.